Annual EBITDA:
$62.35M+$21.81M(+53.80%)Summary
- As of today (October 8, 2025), MDXG annual EBITDA is $62.35 million, with the most recent change of +$21.81 million (+53.80%) on December 31, 2024.
- During the last 3 years, MDXG annual EBITDA has risen by +$61.16 million (+5139.92%).
- MDXG annual EBITDA is now at all-time high.
Performance
MDXG EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$15.53M+$4.08M(+35.62%)Summary
- As of today (October 8, 2025), MDXG quarterly EBITDA is $15.53 million, with the most recent change of +$4.08 million (+35.62%) on June 30, 2025.
- Over the past year, MDXG quarterly EBITDA has dropped by -$8.68 million (-35.85%).
- MDXG quarterly EBITDA is now -38.41% below its all-time high of $25.22 million, reached on December 31, 2017.
Performance
MDXG Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$51.13M-$8.68M(-14.52%)Summary
- As of today (October 8, 2025), MDXG TTM EBITDA is $51.13 million, with the most recent change of -$8.68 million (-14.52%) on June 30, 2025.
- Over the past year, MDXG TTM EBITDA has dropped by -$15.35 million (-23.09%).
- MDXG TTM EBITDA is now -23.40% below its all-time high of $66.74 million, reached on September 30, 2024.
Performance
MDXG TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MDXG EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +53.8% | -35.9% | -23.1% |
| 3Y3 Years | +5139.9% | +287.4% | +555.9% |
| 5Y5 Years | +611.9% | +496.7% | +295.9% |
MDXG EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +683.8% | -35.9% | +368.9% | -23.4% | +360.0% |
| 5Y | 5-Year | at high | +270.7% | -35.9% | +217.3% | -23.4% | +239.9% |
| All-Time | All-Time | at high | +270.7% | -38.4% | +204.0% | -23.4% | +239.9% |
MDXG EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $15.53M(+35.6%) | $51.13M(-14.5%) |
| Mar 2025 | - | $11.45M(-3.8%) | $59.81M(-4.1%) |
| Dec 2024 | $62.35M(+53.8%) | $11.90M(-2.7%) | $62.35M(-6.6%) |
| Sep 2024 | - | $12.23M(-49.5%) | $66.74M(+0.4%) |
| Jun 2024 | - | $24.22M(+73.0%) | $66.47M(+23.2%) |
| Mar 2024 | - | $14.00M(-14.1%) | $53.98M(+33.1%) |
| Dec 2023 | $40.54M(+479.6%) | $16.29M(+36.1%) | $40.54M(+52.3%) |
| Sep 2023 | - | $11.97M(+2.1%) | $26.62M(+199.9%) |
| Jun 2023 | - | $11.72M(+1977.5%) | $8.88M(+179.8%) |
| Mar 2023 | - | $564.00K(-76.2%) | -$11.13M(+43.4%) |
| Dec 2022 | -$10.68M(-997.6%) | $2.37M(+141.1%) | -$19.67M(-13.8%) |
| Sep 2022 | - | -$5.78M(+30.3%) | -$17.27M(-54.0%) |
| Jun 2022 | - | -$8.29M(-4.0%) | -$11.21M(-614.3%) |
| Mar 2022 | - | -$7.97M(-267.4%) | -$1.57M(-232.2%) |
| Dec 2021 | $1.19M(+103.3%) | $4.76M(+1571.6%) | $1.19M(+107.1%) |
| Sep 2021 | - | $285.00K(-79.0%) | -$16.82M(+32.1%) |
| Jun 2021 | - | $1.35M(+126.0%) | -$24.75M(+17.6%) |
| Mar 2021 | - | -$5.21M(+60.6%) | -$30.02M(+17.8%) |
| Dec 2020 | -$36.53M(-199.9%) | -$13.24M(-73.1%) | -$36.53M(-40.0%) |
| Sep 2020 | - | -$7.65M(-95.3%) | -$26.10M(-1108.8%) |
| Jun 2020 | - | -$3.92M(+66.6%) | -$2.16M(+83.6%) |
| Mar 2020 | - | -$11.73M(-318.3%) | -$13.18M(-7.8%) |
| Dec 2019 | -$12.18M(-507.2%) | -$2.80M(-117.2%) | -$12.22M(-29.8%) |
| Sep 2019 | - | $16.29M(+209.0%) | -$9.42M(+60.2%) |
| Jun 2019 | - | -$14.94M(-38.7%) | -$23.66M(-329.9%) |
| Mar 2019 | - | -$10.77M(-625.9%) | -$5.50M(-115.8%) |
| Dec 2018 | $2.99M(-94.2%) | - | - |
| Sep 2018 | - | $2.05M(-36.4%) | $34.93M(-19.1%) |
| Jun 2018 | - | $3.22M(-27.6%) | $43.16M(-11.5%) |
| Mar 2018 | - | $4.44M(-82.4%) | $48.77M(-8.1%) |
| Dec 2017 | $51.99M(+108.0%) | $25.22M(+145.5%) | $53.08M(+40.6%) |
| Sep 2017 | - | $10.27M(+16.3%) | $37.74M(+11.4%) |
| Jun 2017 | - | $8.84M(+1.0%) | $33.88M(+12.9%) |
| Mar 2017 | - | $8.74M(-11.6%) | $30.01M(+20.1%) |
| Dec 2016 | $24.99M | $9.89M(+54.3%) | $24.99M(+5.7%) |
| Sep 2016 | - | $6.41M(+29.0%) | $23.64M(-4.1%) |
| Jun 2016 | - | $4.97M(+33.4%) | $24.65M(-5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $3.72M(-56.4%) | $25.99M(-4.1%) |
| Dec 2015 | $27.10M(+193.7%) | $8.54M(+15.1%) | $27.10M(+14.0%) |
| Sep 2015 | - | $7.42M(+17.6%) | $23.78M(+15.2%) |
| Jun 2015 | - | $6.31M(+30.5%) | $20.63M(+42.7%) |
| Mar 2015 | - | $4.83M(-7.3%) | $14.46M(+56.7%) |
| Dec 2014 | $9.22M(+1254.3%) | $5.22M(+22.0%) | $9.22M(+165.0%) |
| Sep 2014 | - | $4.28M(+3240.8%) | $3.48M(+674.0%) |
| Jun 2014 | - | $128.00K(+132.3%) | -$606.50K(+43.4%) |
| Mar 2014 | - | -$396.60K(+24.6%) | -$1.07M(-98.2%) |
| Dec 2013 | -$799.20K(-454.2%) | -$526.20K(-379.4%) | -$540.80K(-47.8%) |
| Sep 2013 | - | $188.30K(+155.8%) | -$365.80K(+26.5%) |
| Jun 2013 | - | -$337.40K(-350.9%) | -$497.70K(-380.7%) |
| Mar 2013 | - | $134.50K(+138.3%) | $177.30K(+223.0%) |
| Dec 2012 | -$144.20K(+98.2%) | -$351.20K(-722.7%) | -$144.20K(+91.9%) |
| Sep 2012 | - | $56.40K(-83.3%) | -$1.77M(+41.8%) |
| Jun 2012 | - | $337.60K(+280.5%) | -$3.05M(+43.0%) |
| Mar 2012 | - | -$187.00K(+90.6%) | -$5.35M(+32.9%) |
| Dec 2011 | -$7.97M(+15.4%) | -$1.98M(-62.4%) | -$7.97M(+5.4%) |
| Sep 2011 | - | -$1.22M(+38.0%) | -$8.42M(+16.2%) |
| Jun 2011 | - | -$1.97M(+29.9%) | -$10.06M(+4.3%) |
| Mar 2011 | - | -$2.81M(-15.4%) | -$10.51M(-36.4%) |
| Dec 2010 | -$9.42M(+13.5%) | -$2.43M(+14.8%) | -$7.71M(-46.1%) |
| Sep 2010 | - | -$2.85M(-17.9%) | -$5.27M(-117.9%) |
| Jun 2010 | - | -$2.42M(-32.6%) | -$2.42M(+75.3%) |
| Jun 2009 | - | -$1.82M(+29.7%) | -$9.79M(+10.1%) |
| Mar 2009 | - | -$2.59M(-27.3%) | -$10.89M(-34.7%) |
| Mar 2009 | -$10.89M(-7.0%) | - | - |
| Dec 2008 | - | -$2.04M(+38.8%) | -$8.08M(+5.8%) |
| Sep 2008 | - | -$3.33M(-13.8%) | -$8.58M(-63.2%) |
| Jun 2008 | - | -$2.93M(-1478.8%) | -$5.25M(-124.8%) |
| Mar 2008 | -$10.17M(-1421.0%) | $212.20K(+108.4%) | -$2.34M(+8.9%) |
| Dec 2007 | - | -$2.54M(>-9900.0%) | -$2.57M(-8624.8%) |
| Sep 2007 | - | -$5000.00(+41.2%) | -$29.40K(-20.5%) |
| Jun 2007 | - | -$8500.00(+46.5%) | -$24.40K(-53.5%) |
| Mar 2007 | - | -$15.90K | -$15.90K |
| Mar 2007 | -$668.80K(-4054.0%) | - | - |
| Dec 2006 | -$16.10K | - | - |
FAQ
- What is MiMedx Group, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for MiMedx Group, Inc.?
- What is MiMedx Group, Inc. annual EBITDA year-on-year change?
- What is MiMedx Group, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for MiMedx Group, Inc.?
- What is MiMedx Group, Inc. quarterly EBITDA year-on-year change?
- What is MiMedx Group, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for MiMedx Group, Inc.?
- What is MiMedx Group, Inc. TTM EBITDA year-on-year change?
What is MiMedx Group, Inc. annual EBITDA?
The current annual EBITDA of MDXG is $62.35M
What is the all-time high annual EBITDA for MiMedx Group, Inc.?
MiMedx Group, Inc. all-time high annual EBITDA is $62.35M
What is MiMedx Group, Inc. annual EBITDA year-on-year change?
Over the past year, MDXG annual EBITDA has changed by +$21.81M (+53.80%)
What is MiMedx Group, Inc. quarterly EBITDA?
The current quarterly EBITDA of MDXG is $15.53M
What is the all-time high quarterly EBITDA for MiMedx Group, Inc.?
MiMedx Group, Inc. all-time high quarterly EBITDA is $25.22M
What is MiMedx Group, Inc. quarterly EBITDA year-on-year change?
Over the past year, MDXG quarterly EBITDA has changed by -$8.68M (-35.85%)
What is MiMedx Group, Inc. TTM EBITDA?
The current TTM EBITDA of MDXG is $51.13M
What is the all-time high TTM EBITDA for MiMedx Group, Inc.?
MiMedx Group, Inc. all-time high TTM EBITDA is $66.74M
What is MiMedx Group, Inc. TTM EBITDA year-on-year change?
Over the past year, MDXG TTM EBITDA has changed by -$15.35M (-23.09%)